​Dr. Wayne Danter is the founder of 123Genetix and is a pioneer in the evolving interface between artificial intelligence (“AI”) and pharmacotherapeutics.  He has conducted extensive research on the medical application of AI technologies to disease diagnosis, outcome prediction and personalized therapies.  Much of his research has focused on developing Hybrid AI models of the relationships between molecular structure and biological activity. His research has been published in peer-reviewed journals and he has been an invited presenter and panelist at numerous international meetings.
 
Prior to founding 123Genetix, Dr. Danter was the President, CEO and CSO of Critical Outcome Technologies Inc., which he also founded. While at Critical Outcome Technologies, he invented a proprietary, AI-based technology platform that utilizes a series of predictive computer models to identify compounds with a high probability of being successfully developed from disease specific drug discovery and chemical optimization through preclinical testing and early clinical testing.
 
Earlier in his career, Dr. Danter was an Associate Professor of Medicine at the University of Western Ontario (now Western University).  His clinical focus at the University was in General Cardiology, Cardiovascular Diseases associated with HIV, and Cardiovascular Risk Management.  Dr. Danter trained at the University of Western Ontario in Internal Medicine, Clinical Pharmacology and Critical Care. 

It's Rare Disease Day today. Organizations around the globe are continuing their efforts to spread awareness about rare diseases, organizations, research efforts, and treatments. In honour of those efforts everywhere, we have put together this presentation on the Top 5 Facts About Rare Diseases. Please share.